Related Experiment Video
Updated: Aug 6, 2026

09:39
Constructing a Collagen Hydrogel for the Delivery of Stem Cell-loaded Chitosan Microspheres
Published on: June 1, 2012
Temperature-responsive Rehmannia polysaccharides hydrogel loaded with bone marrow mesenchymal stem cells for bone
Bin Huang1, Jialing Liu1, Jin Cheng2
1Affiliated Jiangning Traditional Chinese Medicine Hospital, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, PR China.
International Journal of Biological Macromolecules
|July 21, 2026
Summary
Rehmannia glutinosa polysaccharide RP-1 promotes bone marrow mesenchymal stem cell proliferation and osteogenic differentiation. RP-1 hydrogels loaded with BMSCs show significant bone defect repair in vitro and in vivo.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Plant-derived Therapeutics
Background:
- Rehmannia, a traditional medicinal plant, contains bioactive polysaccharides.
- Polysaccharide hydrogels loaded with bone marrow mesenchymal stem cells (BMSCs) are promising for bone defect repair.
- A neutral homogeneous polysaccharide, RP-1, was isolated from Rehmannia glutinosa.
Purpose of the Study:
- To investigate the potential of RP-1 and RP-1 hydrogels loaded with BMSCs (RPB@Gel) for bone defect repair.
- To evaluate the effect of RP-1 on BMSC proliferation and osteogenic differentiation.
- To assess the efficacy of RPB@Gel in promoting bone regeneration both in vitro and in vivo.
Main Methods:
- Isolation and characterization of RP-1 polysaccharide from Rehmannia glutinosa.
- In vitro studies on BMSC proliferation and osteogenic differentiation stimulated by RP-1.
- Preparation and characterization of temperature-sensitive RPB@Gel hydrogels.
- In vitro and in vivo validation of RPB@Gel efficacy for bone defect repair using cell assays, micro-CT, histology, and immunohistochemistry.
Main Results:
- RP-1 significantly promoted BMSC proliferation and osteogenic differentiation in vitro.
- RPB@Gel hydrogels exhibited rapid cross-linking at body temperature.
- In vitro studies showed RPB@Gel upregulated osteogenic markers (RUNX2, ALP, Col1a1) in BMSCs via ERK and β-catenin pathways.
- In vivo studies demonstrated significant bone defect repair by RPB@Gel, confirmed by micro-CT, histological, and immunohistochemical analyses.
Conclusions:
- RP-1 acts as both a bioactive component and a structural carrier for bone defect repair.
- RPB@Gel hydrogels effectively promote bone regeneration by enhancing BMSC activity and facilitating new bone formation.
- RPB@Gel represents a potential therapeutic strategy for bone regeneration applications.

